Dr. Martens Plc logo

Dr. Martens Plc(LSE) DOCS

Market Cap£658.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-82%
5 Year-82%
1 Year-24%
1 Month+1%
£0.68
-1.60%
-0.01Today
Dr. Martens Plc last closing stock price
MetricPriceDate
Last closeGBX 67.702026-10-19
Dr. Martens Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.74%GBX 68.902026-10-12
1 month+0.59%GBX 67.302026-09-18
3 month-9.25%GBX 74.602026-07-21
Year to date-11.62%GBX 76.602025-12-31
1 year-24.19%GBX 89.302025-10-17
3 year-42.33%GBX 117.402023-10-20
5 year-81.58%GBX 367.602021-10-20
Since inception-82.11%GBX 3.852021-01-29

Dr. Martens Plc Financials at a Glance

Market Cap

£658.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.55B

Net Income (TTM)

£28.30M

EPS (TTM)

£0.02

P/E Ratio

27.85

Dividend

£0.03

Beta (Volatility)

-0.09 (Low)

Price

£0.68

Volume

852,441

Open

£0.72

Previous Close

£0.68

Daily Range

£0.68 - £0.72

52-Week Range

£0.59 - £0.97

Estimated Earnings Date

Nov 12, 2026

DOCS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dr. Martens Plc

Dr. Martens plc is a global footwear enterprise known for its iconic boots and shoes. Established in 1945, the company has a significant international presence, serving customers across various regions including Europe, the Americas, and Asia-Pacific.

Products and Services
  • Classic 'Originals' footwear and contemporary 'fusion' styles
  • Children's shoes and casual designs
  • Various accessories offered exclusively under the Dr. Martens brand
Growth Outlook
  • Revenue of £442.9 million in the latest quarter, showing strong demand
  • Gross profit margin improved to 59% in Q4 2026
  • Expansion plans in Asia-Pacific to capture emerging markets
Financial Highlights
  • Net income of £33.8 million reported in Q4 2026
  • Trailing twelve months (TTM) revenue of £1.7 billion, indicating steady growth
  • Dividend yield of 3.75%, reflecting commitment to shareholder returns
Dr. Martens plc has established itself as a leader in the footwear industry, with a diverse product range that appeals to various consumer segments. The company's recent financial performance highlights its resilience and ability to adapt to market demands. The latest quarterly results indicate a robust revenue stream and a solid gross profit margin, suggesting effective cost management and strong brand loyalty. With ongoing expansion efforts, particularly in the Asia-Pacific region, Dr. Martens is well-positioned for future growth. The commitment to returning value to shareholders through dividends further enhances its attractiveness as a potential investment opportunity.
AI Generated • Oct 11, 2026

Industry

Textiles, Apparel and Luxury Goods

Employees

2,377

CEO

Ije Nwokorie

Headquarters

London, GL NW1 7BY, GB

DOCS Financials

Key Financial Metrics (TTM)

Gross Margin

57.17%

Operating Margin

10.01%

Net Income Margin

3.11%

Return on Equity

6.89%

Return on Capital

9.72%

Return on Assets

2.71%

Earnings Yield

3.59%

Dividend Yield

3.71%

Payout Ratio

1.03%

Stock Overview

Market Cap

£658.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

957.17M

Volume

852.44K

Avg. Volume

1.14M

Financials (TTM)

Gross Profit

£949.00M

Operating Income

£132.70M

EBITDA

£255.80M

Operating Cash Flow

£303.30M

Capital Expenditure

-£17.60M

Free Cash Flow

£285.70M

Cash & ST Invst.

£180.30M

Total Debt

£393.50M

Dr. Martens Plc Performance Analysis

Dr. Martens Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP 1,000,300,00010.1%
20242024-03-31GBP 877,100,000-12.3%
20252025-03-31GBP 787,600,000-10.2%
20262026-03-31GBP 766,200,000-2.7%
Dr. Martens Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-32.6%
Q42025-03-3042.6%
Q22025-09-30-30.5%
Q42026-03-3137.5%
Dr. Martens Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP 0.13-28.7%
20242024-03-31GBP 0.07-45.5%
20252025-03-31GBP 0.00-93.4%
20262026-03-31GBP 0.02428.3%
Dr. Martens Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-142.5%
Q42025-03-30219.1%
Q22025-09-30-139.7%
Q42026-03-31432.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

£442.90M

-8.0%

Gross Profit

£261.60M

-18.3%

Gross Margin

59.07%

N/A

Market Cap

£658.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£277.04K

N/A

Employees

2,377

N/A

Net Income

£33.80M

-32.7%

EBITDA

£107.40M

-10.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

£180.30M

+62.3%

Total Debt

£393.50M

-16.0%

Accounts Receivable

£69.00M

+11.3%

Inventory

£160.80M

-36.8%

Long Term Debt

£347.30M

-17.6%

Short Term Debt

£46.20M

-1.7%

Return on Assets

2.71%

N/A

Return on Invested Capital

10.68%

N/A

Free Cash Flow

£136.60M

-26.2%

Operating Cash Flow

£141.60M

-26.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASC.LASOS Plc
£4.60-0.86%
FRAS.LFrasers Group plc
£8.74+0.63%
BRBY.LBurberry Group plc
£11.01-0.14%
MKS.LMarks and Spencer Group plc
£4.20+2.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.03+2.43%
CRWVCoreWeave
$61.12-0.44%
NVDANvidia
$217.09+1.38%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$98.65+5.32%

Questions About DOCS

What is the current price of Dr. Martens Plc?

Dr. Martens Plc is trading at £0.68 per share.

What is the 52-week range for Dr. Martens Plc?

Over the past 52 weeks, Dr. Martens Plc has traded between £0.59 and £0.97.

How much debt does Dr. Martens Plc have?

As of the most recent reporting period, Dr. Martens Plc reported total debt of £391.40M.

How much cash does Dr. Martens Plc have on hand?

Dr. Martens Plc reported £180.30M in cash and cash equivalents in its most recent financial results.

What is Dr. Martens Plc’s dividend yield?

Dr. Martens Plc currently has a dividend yield of 3.71%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.